Peak Pharma

This book argues that we have reached the ‘peak’ of a particular model for pharmaceutical innovation—the neoliberal value model that has been in place since the early 1980s. ‘Peak’ designates a state where a given and socially significant resource becomes rarer, more difficult to access, and more ex...

Descripció completa

Dades bibliogràfiques

Autors principals:	Geiger, Susi, Bourgeron, Théo
Format:	Online
Idioma:	anglès
Publicat:	Oxford University Press 2026
Matèries:	Health social movements Patient organizations Market failures Neoliberal regime Pharmaceutical markets Commons Political economy of pharmaceuticals Access to medicines Patents thema EDItEUR::K Economics, Finance, Business and Management::KC Economics::KCV Economics of specific sectors::KCVJ Health economics thema EDItEUR::K Economics, Finance, Business and Management::KC Economics thema EDItEUR::J Society and Social Sciences::JH Sociology and anthropology::JHB Sociology
Accés en línia:	https://library.oapen.org/handle/20.500.12657/111395
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!